The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 24: 3153 - 3157

DOI: https://doi.org/10.3969/j.issn.1006-5725.2023.24.001

Clinical Advances

The mechanisms and the diagnosis progress of non⁃obstructive mesenteric ischemia after cardiac surgery

  • Yingjing ZHAO ,
  • Xiao SHEN ,
  • Liang HONG ,
  • Cui. ZHANG
Expand
  • Department of Critical Care Medicine，Nanjing First hospital，Nanjing Medical University，Nanjing 210006，China

Received date: 2023-08-30

  Online published: 2024-01-10

Fold

Abstract

Non?occlusive mesenteric ischemia （NOMI） is a series of disorders of digestive tract caused by local blood perfusion damage， which is caused by vasospasm. As an extremely dangerous disease， NOMI is also a common intestinal complication in intensive care unit， especially in patients with hemodynamic instability after cardiac surgery， and the mortality is high. Cardiac surgery aims to improve the prognosis of patients， while the complication of NOMI is easy to be ignored， which hindered the recovery of postoperative patients. Due to the rapid development and lack of specific symptoms and signs， NOMI is easily misdiagnosed as other gastrointestinal complications. Therefore， timely and effective diagnosis of NOMI is the most important factor affecting the prognosis of post cardiac surgery. This review systematically summarized the related research on NOMI after cardiac surgery， and comprehensively concluded the cause， mechanism， treatment as well as prognosis of NOMI. Then we emphasized on the latest progresses of diagnostic methods for NOMI， in order to provide directions on the accurate identification and timely intervention of NOMI in clinical work.

Key words： non-obstructive mesenteric ischemia; cardiac surgery; complication; diagnostic methods

Cite this article

Yingjing ZHAO , Xiao SHEN , Liang HONG , Cui. ZHANG . The mechanisms and the diagnosis progress of non⁃obstructive mesenteric ischemia after cardiac surgery[J]. The Journal of Practical Medicine, 2023 , 39(24) : 3153 -3157 . DOI: 10.3969/j.issn.1006-5725.2023.24.001

References

1 BALA M， CATENA F， KASHUK J， et al. Acute mesenteric ischemia： updated guidelines of the World Society of Emergency Surgery［J］. World J Emerg Surg， 2022， 17（1）： 54.
2 GUILLAUME A， PILI-FLOURY S， CHOCRON S， et al. Acute Mesenteric Ischemia Among Postcardiac Surgery Patients Presenting with Multiple Organ Failure［J］ . Shock， 2017， 47（3）： 296-302.
3 GROESDONK H V， KLINGELE M， SCHLEMPP S， et al. Risk factors for nonocclusive mesenteric ischemia after elective cardiac surgery［J］. J Thorac Cardiovasc Surg，2013， 145（6）： 1603-1610.
4 QUIROGA B， VERDE E， ABAD S， et al. Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis［J］ . J Surg Res， 2013， 180（1）： 51-55.
5 TOPOLSKY A， PANTET O， LIAUDET L， et al. MDCT-findings in patients with non-occlusive mesenteric ischemia （NOMI）： influence of vasoconstrictor agents［J］ . Eur Radiol， 2023， 33（5）： 3627-3637.
6 ACOSTA S， OGREN M， STERNBY N H， et al. Fatal nonocclusive mesenteric ischaemia： population-based incidence and risk factors［J］. J Intern Med， 2006， 259（3）： 305-313.
7 K?RKK?INEN J M， LEHTIM?KI T T， MANNINEN H， et al. Acute Mesenteric Ischemia Is a More Common Cause than Expected of Acute Abdomen in the Elderly［J］ J Gastrointest Surg， 2015， 19（8）： 1407-1414.
8 PAUL M， BOUGOUIN W， LEGRIEL S， et al. Frequency， risk factors， and outcomes of non-occlusive mesenteric ischaemia after cardiac arrest［J］. Resuscitation，2020， 157： 211-218.
9 SOUSSI S， TACCORI M， DE TYMOWSKI C， et al. Risk Factors for Acute Mesenteric Ischemia in Critically Ill Burns Patients-A Matched Case-Control Study［J］. Shock，2019， 51（2）： 153-160.
10 TAMME K， REINTAM BLASER A， LAISAAR K T， et al. Incidence and outcomes of acute mesenteric ischaemia： a systematic review and meta-analysis［J］ . BMJ Open， 2022， 12（10）： e062846.
11 HOWARD T J， PLASKON L A， WIEBKE E A， et al. Nonocclusive mesenteric ischemia remains a diagnostic dilemma［J］ . Am J Surg， 1996， 171（4）： 405-408.
12 VERDOT P， CALAME P， WINISZEWSKI H， et al. Diagnostic performance of CT for the detection of transmural bowel necrosis in non-occlusive mesenteric ischemia［J］ . Eur Radiol， 2021， 31（9）： 6835-6845.
13 ERIS C， YAVUZ S， YALCINKAYA S， et al. Acute mesenteric ischemia after cardiac surgery： an analysis of 52 patients［J］. Scientific World J，2013， 2013： 631534.
14 ASFAR P， BRACHT H， RADERMACHER P. Impact of vasopressin analogues on the gut mucosal microcirculation［J］ . Best Pract Res Clin Anaesthesiol， 2008， 22（2）： 351-358.
15 PITON G， LE GOUGE A， BOISRAMé-HELMS J， et al. Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock： a post hoc analysis of the NUTRIREA2 trial［J］. Intensive Care Med， 2022， 48（4）： 458-466.
16 RUSSELL J A， WALLEY K R， SINGER J， et al. Vasopressin versus norepinephrine infusion in patients with septic shock［J］ . N Engl J Med， 2008， 358（9）： 877-887.
17 SUYAMA Y， HANDA O， NAITO Y， et al. Mucus reduction promotes acetyl salicylic acid-induced small intestinal mucosal injury in rats［J］. Biochem Biophys Res Commun， 2018， 498（1）： 228-233.
18 DUBIN A， EDUL V S K， POZO M O， et al. Persistent villi hypoperfusion explains intramucosal acidosis in sheep endotoxemia［J］. Crit Care Med， 2008， 36（2）： 535-542.
19 PITON G， CAPELLIER G， DELABROUSSE E. Echography of the Portal Vein in a Patient With Shock［J］ . Crit Care Med， 2016， 44（6）： e443-e445.
20 L'HER E， CASSAZ C， LE GAL G， et al. Gut dysfunction and endoscopic lesions after out-of-hospital cardiac arrest［J］ . Resuscitation，2005， 66（3）： 331-334.
21 GROESDONK H V， RAFFEL M， SPEER T， et al. Elevated endothelin-1 level is a risk factor for nonocclusive mesenteric ischemia［J］. J Thorac Cardiovasc Surg，2015， 149（5）： 1436-42.e2.
22 VIERHAPPER H， WAGNER O， NOWOTNY P， et al. Effect of endothelin-1 in man［J］. Circulation， 1990， 81（4）： 1415-1418.
23 SHI H， WU B， WAN J， et al. The role of serum intestinal fatty acid binding protein levels and D-lactate levels in the diagnosis of acute intestinal ischemia［J］. Clin Res Hepatol Gastroenterol， 2015， 39（3）： 373-378.
24 CRONK D R， HOUSEWORTH T P， CUADRADO D G， et al. Intestinal fatty acid binding protein （I-FABP） for the detection of strangulated mechanical small bowel obstruction［J］ . Curr Surg，2006， 63（5）： 322-325.
25 NIEWOLD T A， MEINEN M and VAN DER MEULEN J. Plasma intestinal fatty acid binding protein （I-FABP） concentrations increase following intestinal ischemia in pigs［J］ . Res Vet Sci， 2004， 77（1）： 89-91.
26 TIMMERMANS K， SIR ?， KOX M， et al. Circulating iFABP Levels as a marker of intestinal damage in trauma patients［J］ . Shock， 2015， 43（2）： 117-120.
27 VOTH M， LUSTENBERGER T， RELJA B， et al. Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients？［J］. World J Emerg Surg，2019， 14： 49.
28 NUZZO A， GUEDJ K， CURAC S， et al. Accuracy of citrulline， I-FABP and D-lactate in the diagnosis of acute mesenteric ischemia［J］. Sci Rep， 2021， 11（1）： 18929.
29 MACE M L， GRAVESEN E， HOFMAN-BANG J， et al. Key role of the kidney in the regulation of fibroblast growth factor 23［J］ . Kidney Int，2015， 88（6）： 1304-1313.
30 NAVARRO-GARCíA J A， FERNáNDEZ-VELASCO M， DELGADO C， et al. PTH， vitamin D， and the FGF-23-klotho axis and heart： Going beyond the confines of nephrology［J］ Eur J Clin Invest， 2018， 48（4）.
31 HEINE G H， SEILER S and FLISER D. FGF-23： the rise of a novel cardiovascular risk marker in CKD［J］. Nephrol Dial Transplant， 2012， 27（8）： 3072-3081.
32 SEILER S， CREMERS B， REBLING N M， et al. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation［J］ . Eur Heart J， 2011， 32（21）： 2688-2696.
33 STROEDER J， KLINGELE M， BOMBERG H， et al. Occurrence and severity of non-occlusive mesenteric ischemia （NOMI） after cardiovascular surgery correlate with preoperatively assessed FGF-23 levels［J］. PLoS One，2017， 12（8）： e0182670.
34 SANDQUIST M， WONG H R. Biomarkers of sepsis and their potential value in diagnosis， prognosis and treatment［J］ . Expert Rev Clin Immunol，2014， 10（10）： 1349-1356.
35 STROEDER J， BOMBERG H， WAGENPFEIL S， et al. Presepsin and Inflammatory Markers Correlate With Occurrence and Severity of Nonocclusive Mesenteric Ischemia After Cardiovascular Surgery［J］. Crit Care Med， 2018， 46（6）： e575-e583.
36 MITSUYOSHI A， OBAMA K， SHINKURA N， et al. Survival in nonocclusive mesenteric ischemia： early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E（1）［J］. Ann Surg， 2007， 246（2）： 229-235.
37 CLAIR D G， BEACH J M. Mesenteric Ischemia［J］. N Engl J Med， 2016， 374（10）： 959-968.
38 WINZER R， FEDDERS D， BACKES M， et al. Local Intra-arterial Vasodilator Infusion in Non-Occlusive Mesenteric Ischemia Significantly Increases Survival Rate［J］. Cardiovasc Intervent Radiol， 2020， 43（8）： 1148-1155.
Options
Outlines

/

〈 〉